News

Article Date: 20 Oct 2009 - 5:00 PDT

Mangosteen juice has anti-inflammatory properties which could prove to be valuable in preventing the development of heart disease and diabetes in obese patients. A study, published in BioMed Central's open access Nutrition Journal, describes how the juice of the exotic 'superfruit' lowered levels of C-reactive protein.

Dr. Jay Udani, M.D. from Medicus Research, California, worked with a team of researchers to carry out a randomized, double-blind placebo controlled trial. He said, "For people drinking over half a liter of mangosteen juice a day, the degree of reduction in CRP levels was statistically significant - a reduction of 1.33mg/L compared to an increase of 0.9mg/L in the placebo group".

Inflammation, as measured here by CRP, is a predictor of cardiovascular disease and a precursor of metabolic syndrome. Reducing inflammation in obese people is a treatment goal, and a natural treatment may be preferable to other treatments which may carry the risk of side effect. According to Udani, "Further studies with a larger population are required to confirm and further define the benefits of this juice, which was safe at all dosages tested".

Notes:
Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study.
Jay K Udani, Betsy B Singh, Marilyn L Barrett and Vijay J Singh
Nutrition Journal (in press)
 

Source:
Charlotte Webber
BioMed Central

Links of Interest

"There is a growing trend of utilizing telehealth to reduce strain on intake clinincs. The remote capabilitites and unparalleled accuracy of CSI's Health Systems will significantly offset the impact of overcrowded medical facilities. Patients no longer have to wait to receive treatment, and can take a proactive approach to health."

- Ken Lucas, Vice President, ViTelNet